, /PRNewswire/ -- Somatus, the nation's leading and largest value-based kidney care company, made marked improvements in the overall quality of care for a client's complex kidney care population measured across 22 CMS Medicare Advantage Star metrics in 2023 measurement year, 2024 reporting year. Historically, quality ratings for this patient population have been in the 2-Star range due to the inherent clinical complexity of kidney disease and the disproportionate impact of kidney disease on disadvantaged populations. However, Somatus multidisciplinary in-home care teams worked closely alongside community provider partners to improve quality of care for the Somatus membership, which started at a 2.
5-Star rating and ended at a 4-Star performance rating for 2023 measurement year, 2024 reporting year. Somatus' whole-person approach to care prioritizes preventive care and results in improvements across both traditional cardiovascular-kidney-metabolic quality metrics like blood pressure and HbA1c control outcomes, as well as colorectal and breast cancer screening, osteoporosis management, and all-cause hospital readmissions. said Dr.
, Somatus Chief Medical Officer, and primary care internist. Additionally, Somatus' clinical model focuses on promoting health equity and addressing the longstanding disparities in outcomes among patients with kidney disease. According to the National Institute of Diabetes and Digestive and Kidney Diseases, Black individuals are nearly four times more .
